• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

研究喹诺酮键合氨基胍作为新型抗菌剂。

Investigation of quinolone-tethered aminoguanidine as novel antibacterial agents.

机构信息

Department of Pharmaceutical Chemistry, Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa.

SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Department of Pathology, University of Cape Town, Observatory, South Africa.

出版信息

Arch Pharm (Weinheim). 2022 Oct;355(10):e2200172. doi: 10.1002/ardp.202200172. Epub 2022 Jun 8.

DOI:10.1002/ardp.202200172
PMID:35674486
Abstract

A recent study identified quinolone-based thiosemicarbazone with an MIC value of 2 µM against Mycobacterium tuberculosis (Mtb). Herein, we report further optimization of the previous hit, which led to the discovery of quinolone-tethered aminoguanidine molecules with generally good antitubercular activity. Compounds 7f and 8e emerged as the hits of the series with submicromolar antitubercular activity, exhibiting MIC values of 0.49/0.90 and 0.49/0.60 µM, respectively, in the 7H9 CAS GLU Tx medium. This shows a fivefold increase in antitubercular activity compared to the previous study. Target compounds were also screened against ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens. However, the series generally exhibited poor antibacterial activities, with only compounds 8d and 8e demonstrating >50% growth inhibition of Staphylococcus aureus and Pseudomonas aeruginosa at 32 µg/ml. The compounds displayed selective antitubercular activity as they showed no cytotoxicity effects against two noncancerous human cell lines. In silico studies predict 7f to have good solubility, no inhibitory effect on cytochrome P450 isoenzymes, and to be a non-pan-assay interfering compound.

摘要

最近的一项研究发现,一种对结核分枝杆菌(Mtb)具有 2μM 的 MIC 值的基于喹诺酮的硫代缩氨基脲。在此,我们报告了对先前的命中化合物的进一步优化,这导致了发现具有一般良好抗结核活性的喹诺酮连接的氨基胍分子。化合物 7f 和 8e 作为该系列的命中化合物出现,具有亚微摩尔抗结核活性,在 7H9 CAS GLU Tx 培养基中的 MIC 值分别为 0.49/0.90 和 0.49/0.60μM。这表明与之前的研究相比,抗结核活性增加了五倍。目标化合物也针对 ESKAPE(粪肠球菌、金黄色葡萄球菌、肺炎克雷伯菌、鲍曼不动杆菌、铜绿假单胞菌和肠杆菌属)病原体进行了筛选。然而,该系列通常表现出较差的抗菌活性,只有化合物 8d 和 8e 在 32μg/ml 时对金黄色葡萄球菌和铜绿假单胞菌的生长抑制率超过 50%。这些化合物表现出选择性的抗结核活性,因为它们对两种非癌细胞系没有细胞毒性作用。计算机研究预测 7f 具有良好的溶解度、对细胞色素 P450 同工酶没有抑制作用、并且是非全分析干扰化合物。

相似文献

1
Investigation of quinolone-tethered aminoguanidine as novel antibacterial agents.研究喹诺酮键合氨基胍作为新型抗菌剂。
Arch Pharm (Weinheim). 2022 Oct;355(10):e2200172. doi: 10.1002/ardp.202200172. Epub 2022 Jun 8.
2
6-Nitro-1-benzylquinolones exhibiting specific antitubercular activity.具有特异抗结核菌活性的 6-硝基-1-苄基喹啉酮。
Chem Biol Drug Des. 2020 Dec;96(6):1387-1394. doi: 10.1111/cbdd.13747. Epub 2020 Jul 26.
3
Easy-To-Access Quinolone Derivatives Exhibiting Antibacterial and Anti-Parasitic Activities.易于获取的喹诺酮衍生物具有抗菌和抗寄生虫活性。
Molecules. 2021 Feb 20;26(4):1141. doi: 10.3390/molecules26041141.
4
Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens.具有潜在抗 ESKAPE 病原体抗菌活性的喹诺酮杂合物的现状。
Eur J Med Chem. 2023 Feb 5;247:115026. doi: 10.1016/j.ejmech.2022.115026. Epub 2022 Dec 21.
5
Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.羧酸类诺氟沙星盐可抑制 ESKAPE 病原体的浮游和生物膜生长模式。
J Appl Microbiol. 2018 Feb;124(2):408-422. doi: 10.1111/jam.13651.
6
Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.替比培南匹伐酯片(一种新型口服碳青霉烯制剂)对多种病原菌的体内外抗菌特性
Molecules. 2016 Jan 6;21(1):62. doi: 10.3390/molecules21010062.
7
In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens.针对ESKAPE病原体对美国食品药品监督管理局(FDA)批准的文库进行体外筛选。
Curr Pharm Des. 2017;23(14):2147-2157. doi: 10.2174/1381612823666170209154745.
8
Identification of 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol, a Novel Antibacterial Compound Active against Persisters of Pseudomonas aeruginosa.鉴定 1-((2,4-二氯苯乙基)氨基)-3-苯氧基-2-丙醇,一种新型抗铜绿假单胞菌持久期细菌化合物。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00836-17. Print 2017 Sep.
9
Synthesis and study of 1-ethyl-3-carbohydrazide and 3-[1-oxo-2-hydrazino-3-{p-toluenesulfon}]quinolone derivatives against bacterial infections.1-乙基-3-碳酰肼和 3-[1-氧代-2-肼基-3-(对甲苯磺酰基)喹啉]衍生物的合成与研究及其对抗细菌感染的作用。
Eur J Med Chem. 2013 Sep;67:464-8. doi: 10.1016/j.ejmech.2013.06.056. Epub 2013 Jul 9.
10
A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.全细胞筛选发现与多粘菌素协同作用并具有抗多重耐药菌活性的小分子生物活性物质。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01677-19.

引用本文的文献

1
Synthesis, Antimicrobial Activities, and Model of Action of Novel Tetralone Derivatives Containing Aminoguanidinium Moiety.含氨基胍部分的新型四氢萘酮衍生物的合成、抗菌活性及作用模式
Int J Mol Sci. 2025 Jun 21;26(13):5980. doi: 10.3390/ijms26135980.
2
Antioxidant and Anti-Glycation Potential of H2 Receptor Antagonists-In Vitro Studies and a Systematic Literature Review.H2受体拮抗剂的抗氧化和抗糖化潜力——体外研究及系统文献综述
Pharmaceuticals (Basel). 2023 Sep 8;16(9):1273. doi: 10.3390/ph16091273.
3
Quinolone-3-amidoalkanol: A New Class of Potent and Broad-Spectrum Antimicrobial Agent.
喹诺酮-3-酰胺醇:一类新型强效广谱抗菌剂。
ACS Omega. 2023 May 4;8(19):17086-17102. doi: 10.1021/acsomega.3c01406. eCollection 2023 May 16.